© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent

More articles/Ad

More articles/Ad

More articles

  • Saudi Aramco’s IPO last year was a historic event for the company and its owner, Saudi Arabia, but despite a record $29.4bn being raised at IPO, international investors stayed away. They had demanded that the shares offered a discount to other listed oil majors, in part because of the political risk associated with the company. The fact it is now a tool in Saudi Arabia’s oil price war with Russia will have vindicated many in their decision to sit out the deal.
  • Equity capital markets in Europe got off to a great start in the first quarter of 2020, but any optimism about more deal flow has swiftly been killed off by the onset of a global equity market sell-off sparked by the spread of the coronavirus across the globe and the shutdown of major economies.
  • Equity capital markets are adjusting to life in quarantine, with most bankers saying they are well set up to work remotely during Covid-19 lockdowns. Even syndicate bankers, natural sceptics to home working, are starting to have faith that business can be done at a distance.
  • Hong Kong-listed Shanghai Henlius Biotech got the go ahead from its controlling shareholders on Monday for a secondary flotation on China’s Star Market.
  • China-based Sunkwan Properties Group is looking to Hong Kong as a venue to go public, enlisting ABC International as the sponsor for the IPO.
  • Mainland-based Kangji Medical Holdings is seeking approval to list in Hong Kong. It has filed an IPO application with the city’s bourse.